Zusammenfassung
Hereditäre Defekte des Galaktosestoffwechsels führen zu erhöhten Galaktosekonzentrationen in Geweben und Körperflüssigkeiten. Die klinischen Symptome dieser Erkrankungen reichen von asymptomatischen Verlaufsformen bis zu lebensbedrohlichen Krisen in der Neugeborenenperiode und schweren Langzeitkomplikationen. Drei angeborene Enzymdefekte des Galaktosestoffwechsels, die autosomal-rezessiv vererbt werden, sind bekannt.
Der Galaktokinasedefekt führt zu Katarakten, die in den ersten Lebenswochen auftreten und in der Regel beidseitig sind. Ein Pseudotumor cerebri wird inzwischen als häufige klinische Manifestationsform des Galaktokinasedefektes anerkannt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Umrechnung in Stoffmengenkonzentration: mg/dl × 0,047393 = mmol/l.
Literatur
Arnoux JB, Verkarre V, Saint-Martin C et al. (2011) Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 6: 63
AWMF-Leitlinie Kongenitaler Hyperinsulinismus (KHI) - Empfehlungen zu Diagnostik und Therapie. http://www.awmf.org/leitlinien/detail/ll/027-045.html
Berghe G van den (2000) Disorders of fructose metabolism. In: Fernandes J, Saudubray J-M, Berghe G van den (eds) Inborn metabolic diseases: diagnosis and treatment, 3rd edn. Springer, Berlin Heidelberg New York
Froissart R, Piraud M, Boudjemline AM et al. (2011) Glucose-6-phosphatase deficiency. Orphanet J Rare Dis 6: 27
Funke S, Gardeitchik T, Kouwenberg D et al. (2013) Perinatal and early infantile symptoms in congenital disorders of glycosylation. Am J Med Genet 161: 578–584
Gross KC, Acosta PB (1991) Fruits and vegetables are a source of galactose: implications in planning the diets of patients with galactosaemia. J Inherit Metab Dis 14: 253–258
Grünewald S (2009) The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 1792: 827–834
Harris ES, Weyrich AS, Zimmerman GA (2013) Lessons from rare maladies: leukocyte adhesion deficiency syndromes. Curr Opin Hematol 20: 16–25
Hicks J, Wartchow E, Mierau G (2011) Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 35: 183–196
Hilgarth R (1984) Diättherapie bei Glykogenose, Laktose- und Fruktoseintoleranz, Galaktosämie aus der Sicht des Diätassistenten. Ernähr Umschau 31: 143
Item CB, Stöckler-Ipsiroglu S, Stromberger C et al. (2001) Arginine: glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69: 1127–1133
Jumbo-Lucioni PP, Garber K, Kiel J et al. (2012) Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes. J Inherit Metab Dis 35: 1037–1049
Klepper J (2012) GLUT1 deficiency syndrome in clinical practice. Epilepsy Res 2012, 100: 272–277
Leen WG, Klepper J, Verbeek MM et al. (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133: 655–670
Marquardt T, Luhn K, Srikrishna G et al. (1999) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94: 3976–3985
Matthijs G (2005) Research network: EUROGLYCANET: a European network focused on congenital disorders of glycosylation. Eur J Hum Genet 13: 395–397
Meissner T, Beinbrech B, Mayatepek E (1999) Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat 13: 351–361
Morava E, Wosik H, Kárteszi J et al. (2008) Congenital disorder of glycosylation type Ix: review of clinical spectrum and diagnostic steps. J Inherit Metab Dis 31: 450–456
Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 4: 121–138
Nesterova G, Gahl WA (2013) Cystinosis: the evolution of a treatable disease. Pediatr Nephrol 28: 51–59
Niehues R, Hasilik M, Alton G et al. (1998) Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 101: 1414–1420
Rauchenzauner M, Klepper J, Leiendecker B et al. (2008) The ketogenic diet in children with Glut1 deficiency syndrome and epilepsy. J Pediatr 153: 716–718
Santer R, Calado J (2010) Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Clin J Am Soc Nephrol 5: 133–141
Santer R, Klepper J, Baethmann M, De Vivo DC, Voit T (2000) Angeborene Störungen des Glukosetransports. Monatsschr Kinderheilkd 148: 2–11
Schulze A, Ebinger F, Rating D, Mayatepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic Acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74: 413–419
Senniappan S, Shanti B, James C, Hussain K (2012) Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Inherit Metab Dis 35: 589–601
Shah KK, O’Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet (online 07.01.2013)
Stanley CA, Lieu YK, Hsu BY et al. (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338: 1352–1357
Stöckler S, Holzbach U, Hanefeld F et al. (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36: 409–413
Stöckler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46: 149–166
van de Vijver E, van den Berg TK, Kuijpers TW (2013) Leukocyte adhesion deficiencies. Hematol Oncol Clin North Am 27: 101–116
Walter JH, Collins JE, Leonard JV (1999) Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child 80: 93–96
Wong D (2005) Hereditary fructose intolerance. Mol Genet Metab. 85: 165–167
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Muntau, A.C. (2014). Angeborene Störungen des Kohlenhydratstoffwechsels und sonstige angeborene Stoffwechselstörungen. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)